|
|
Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments
Florian Lemaitre
,
Caroline Solas
,
Matthieu Grégoire
,
Laurence Lagarce
,
Laure Elens
et al.
Journal articles
hal-02888066v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pharmacologic treatment of transplant recipients infected with SARS-CoV-2 considerations regarding therapeutic drug monitoring and drug-drug interactions
Laure Elens
,
Loralie J Langman
,
Dennis A Hesselink
,
Stein Bergan
,
Dirk Jan a R Moes
et al.
Journal articles
hal-02563361v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Therapeutic drug monitoring and dosage adjustments of immunosuppressive drugs when combined with nirmatrelvir/ritonavir in patients with COVID-19
Florian Lemaitre
,
Klemens Budde
,
Teun van Gelder
,
Stein Bergan
,
Roland Lawson
et al.
Journal articles
hal-03776369v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy Second Consensus Report
Pierre Marquet
,
Christoph Seger
,
Maria Shipkova
,
Alexander Vinks
,
Pierre Wallemacq
et al.
Journal articles
hal-02150345v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
Stein Bergan
,
Mercè Brunet
,
Dennis A Hesselink
,
Kamisha L Johnson-Davis
,
Paweł K Kunicki
et al.
Journal articles
hal-03216543v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|